Valneva SE VALN
NASDAQ VALN
$6.91 -0.15 (-2.20%)
As of: Sep 4, 2026 · 3:14 PM EDT

Valneva SE (VALN) Invested Capital (2020 - 2026)

Valneva SE (VALN) posted Invested Capital of $21.4 million for Q1 2026, down 89.75% sequentially from $208.6 million in Q4 2025, and up 3.2% YoY from $20.7 million in Q1 2025.

Analysis

Valneva SE (VALN) Invested Capital (2020 - 2026) Analysis & Trends

Valneva SE has reported Invested Capital for 8 years, with the latest figure at $21.4 million in Q1 2026.

  • Quarterly Invested Capital rose 3.2% year-over-year to $21.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $489.4 million (up 12.09% YoY) and the FY2025 annual result came in at $208.6 million, up 2.86% from the prior year.
  • Invested Capital fell to $21.4 million in Q1 2026 per VALN's latest filing, from $208.6 million in the prior quarter.
  • Over five years, Invested Capital peaked at $208.6 million in Q4 2025 and troughed at $12.6 million in Q3 2022.
  • A 5-year average of $84.8 million and a median of $36.8 million in 2023 frame the typical range for Invested Capital.
  • The sharpest annual moves came in 2023 and 2024: Invested Capital slumped 80.61% in 2023, then jumped 741.81% in 2024.
  • Over 5 years, Invested Capital stood at $91.0 million in 2022, then soared by 98.09% to $180.2 million in 2023, then increased by 11.09% to $200.2 million in 2024, then climbed by 4.18% to $208.6 million in 2025, then sank by 89.75% to $21.4 million in 2026.
  • According to Business Quant data, Invested Capital over the past three periods registered $21.4 million, $208.6 million, and $68.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - 19.13 Bn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 1.30 Bn
10 Valneva SE 580.64 Mn 439.38 Mn 1.86 Mn 500.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 500.76 Mn
Mar 31, 2026 303.26 Mn
Dec 31, 2025 519.86 Mn
Sep 30, 2025 371.99 Mn
Jun 30, 2025 401.64 Mn
Mar 31, 2025 374.93 Mn
Dec 31, 2024 393.91 Mn
Sep 30, 2024 428.36 Mn
Jun 30, 2024 546.24 Mn
Mar 31, 2024 402.69 Mn
Dec 31, 2023 328.26 Mn
Sep 30, 2023 799.96 Mn
Jun 30, 2023 311.56 Mn
Mar 31, 2023 339.52 Mn
Dec 31, 2022 718.69 Mn
Sep 30, 2022 137.08 Mn
Jun 30, 2022 114.97 Mn
Mar 31, 2022 246.77 Mn
Dec 31, 2021 92.35 Mn
Dec 31, 2020 164.27 Mn